LERCANIDIPINE Side Effects

7017695-9 | Dizziness, Hypoglycaemia
on Sep 14, 2010 Male patient from GERMANY , 71 years of age, weighting 187.4 lb, was diagnosed with hypertension, diabetes mellitus, restlessness, back pain (What is back pain?), ischaemic heart disease prophylaxis, peripheral arterial occlusive disease and was treated with Lercanidipine (View Usage). Patient experienced the following unwanted or unexpected effects: dizziness (What is dizziness?), hypoglycaemia. Lercanidipine dosage: 10 Mg, Unk. During the same period patient was treated with ENALAPRIL MALEATE (20 Mg, Unk) (View Enalapril Maleate Review and Enalapril Maleate Label ), NOVORAPID (Unk) (View Novorapid Review and Novorapid Label ), LEVEMIR (14 Iu, Unk) (View Levemir Review and Levemir Label ), OPIPRAMOL (50 Mg, Unk) (View Opipramol Review and Opipramol Label ), TARGIN (1 Df, Unk) (View Targin Review and Targin Label ), CLOPIDOGREL (75 Mg, Unk) (View Clopidogrel Review and Clopidogrel Label ), MELPERONE (Unk) (View Melperone Review and Melperone Label ), PLETAL (50 Mg, Unk) (View Pletal Review and Pletal Label ). Patient was hospitalized.

5143515-3 | Cardiovascular Insufficiency, Left Ventricular Failure, Myocardial Infarction, Pneumonia, Sepsis
Patient was taking Lercanidipine (View Usage). Patient had the following side effects: cardiovascular insufficiency, left ventricular failure, myocardial infarction, pneumonia (What is pneumonia?), sepsis (What is sepsis?) on Sep 18, 2006 from GERMANY Additional patient health information: Male patient , 75 years of age, weighting 172.0 lb, was diagnosed with hypertension, cerebral haemorrhage, thrombosis prophylaxis, coronary artery disease (What is coronary artery disease?), pain (What is pain?) and. Lercanidipine dosage: . During the same period patient was treated with NOVOSEVEN (20 Ug/kg, Unk) (View Novoseven Review and Novoseven Label ), ASPIRIN (100 Mg, Qd) (View Aspirin Review and Aspirin Label ), IRBESARTAN (150 Mg, Qd) (View Irbesartan Review and Irbesartan Label ), METOPROLOL TARTRATE (95 Mg, Qd) (View Metoprolol Tartrate Review and Metoprolol Tartrate Label ), MOLSIDOMIN (View Molsidomin Review and Molsidomin Label ), ISOSORBIDE DINITRATE (60 Unk, Qd) (View Isosorbide Dinitrate Review and Isosorbide Dinitrate Label ), MORPHIN /00036302/ (100 Mg, Qd) (View Morphin /00036302/ Review and Morphin /00036302/ Label ). Patient was hospitalized.

5135714-1 | Blood Pressure Increased, Cardiovascular Insufficiency, Coronary Artery Disease, Heart Rate Increased, Left Ventricular Failure, Myocardial Infarction, Pneumonia, Sepsis
Adverse event was reported on Sep 18, 2006 by a Male patient taking Lercanidipine (View Usage) (Dosage: ) was diagnosed with hypertension, cerebral haemorrhage, thrombosis prophylaxis, coronary artery disease (What is coronary artery disease?), pain (What is pain?) and. Location: GERMANY , 75 years of age, weighting 172.0 lb, After Lercanidipine was administered, patient had the following side effects: blood pressure increased, cardiovascular insufficiency, coronary artery disease (What is coronary artery disease?), heart rate increased, left ventricular failure, myocardial infarction, pneumonia (What is pneumonia?), sepsis (What is sepsis?). During the same period patient was treated with NOVOSEVEN (20 Ug/kg, Unk) (View Novoseven Review and Novoseven Label ), ASPIRIN (100 Mg, Qd) (View Aspirin Review and Aspirin Label ), IRBESARTAN (150 Mg, Qd) (View Irbesartan Review and Irbesartan Label ), METOPROLOL TARTRATE (95 Mg, Qd) (View Metoprolol Tartrate Review and Metoprolol Tartrate Label ), MOLSIDOMIN (View Molsidomin Review and Molsidomin Label ), ISOSORBIDE DINITRATE (60 Unk, Qd) (View Isosorbide Dinitrate Review and Isosorbide Dinitrate Label ), MORPHIN /00036302/ (100 Mg, Qd) (View Morphin /00036302/ Review and Morphin /00036302/ Label ). Patient was hospitalized.

5118323-X | Myocardial Infarction, Sepsis
on Sep 18, 2006 Male patient from GERMANY , 75 years of age, weighting 172.0 lb, was diagnosed with cerebral haemorrhage and was treated with Lercanidipine (View Usage). Patient experienced the following unwanted or unexpected effects: myocardial infarction, sepsis (What is sepsis?). Lercanidipine dosage: . During the same period patient was treated with NOVOSEVEN (20 Ug/kg, Unk) (View Novoseven Review and Novoseven Label ), ASPIRIN (100 Mg, Qd) (View Aspirin Review and Aspirin Label ), IRBESARTAN (150 Mg, Qd) (View Irbesartan Review and Irbesartan Label ), METOPROLOL (95 Mg, Qd) (View Metoprolol Review and Metoprolol Label ), MOLSIDOMIN (View Molsidomin Review and Molsidomin Label ), ISOSORBIDE DINITRATE (60 Unk, Qd) (View Isosorbide Dinitrate Review and Isosorbide Dinitrate Label ), MORPHIN /00036302/ (100 Mg, Qd) (View Morphin /00036302/ Review and Morphin /00036302/ Label ), ENOXAPARIN SODIUM (20 Mg, Qd) (View Enoxaparin Sodium Review and Enoxaparin Sodium Label ). Patient was hospitalized.


4902974-9 | Foot Fracture
on Feb 01, 2006 Male patient from UNITED KINGDOM , 43 years of age, weighting 348.3 lb, was treated with Lercanidipine (View Usage). Patient had the following side effects: foot fracture. Lercanidipine dosage: . During the same period patient was treated with COZAAR (View Cozaar Review and Cozaar Label ).